Page last updated: 2024-10-24

regulation of plasma lipoprotein particle levels

Definition

Target type: biologicalprocess

Any process involved in the maintenance of internal levels of plasma lipoprotein particles within an organism. [GOC:BHF]

The regulation of plasma lipoprotein particle levels is a complex process involving a intricate interplay of multiple organs and systems. The liver plays a central role in this process, synthesizing and secreting various lipoprotein particles, including very-low-density lipoproteins (VLDL), low-density lipoproteins (LDL), and high-density lipoproteins (HDL). The intestine also contributes to lipoprotein metabolism by absorbing dietary fats and packaging them into chylomicrons, which are then transported to the liver.

The process begins with the synthesis of VLDL in the liver. VLDL particles contain triglycerides, cholesterol, and phospholipids, and they are primarily responsible for transporting triglycerides from the liver to peripheral tissues. As VLDL circulates in the bloodstream, lipoprotein lipase (LPL), an enzyme found in the capillaries of muscle and adipose tissue, hydrolyzes triglycerides, releasing free fatty acids and glycerol. This process leads to the formation of intermediate-density lipoproteins (IDL), which can be either taken up by the liver or further metabolized into LDL.

LDL, often referred to as "bad cholesterol", is the primary carrier of cholesterol in the blood. It is taken up by cells via the LDL receptor, which plays a crucial role in maintaining cellular cholesterol homeostasis. Excess LDL can accumulate in the arterial walls, contributing to atherosclerosis.

HDL, known as "good cholesterol", is synthesized in the liver and small intestine. HDL particles have a high protein content and are responsible for transporting cholesterol from peripheral tissues back to the liver for excretion. This process, known as reverse cholesterol transport, helps remove excess cholesterol from the bloodstream and plays a vital role in preventing atherosclerosis.

Regulation of lipoprotein metabolism is influenced by various factors, including genetics, diet, and lifestyle. Dietary factors, such as saturated and trans fats, can increase LDL levels and decrease HDL levels. Physical activity and regular exercise, on the other hand, can enhance LPL activity and promote HDL production.

Hormones, such as insulin and thyroid hormones, also play a significant role in lipoprotein metabolism. Insulin promotes the synthesis of VLDL and inhibits the activity of LPL, while thyroid hormones increase the activity of LPL and promote the catabolism of LDL.

Dysregulation of lipoprotein metabolism can lead to various health issues, including atherosclerosis, coronary heart disease, and hypercholesterolemia. Maintaining healthy lipoprotein levels through a balanced diet, regular exercise, and avoiding unhealthy lifestyle choices is essential for overall cardiovascular health.'
"

Proteins (1)

ProteinDefinitionTaxonomy
Diacylglycerol O-acyltransferase 2A diacylglycerol O-acyltransferase 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q96PD7]Homo sapiens (human)

Compounds (3)

CompoundDefinitionClassesRoles
azd7687AZD7687: structure in first source
pf-04620110PF-04620110: a DGAT1 inhibitor; structure in first source
pf-06424439PF-06424439: an inhibitor of diacylglycerol acyltransferase 2; structure in first source